• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对对照组和遗传性I型酪氨酸血症的纯合子进行尿黑酸口服负荷试验。

Oral loading of homogentisic acid in controls and in obligate heterozygotes for hereditary tyrosinemia type I.

作者信息

Laberge C, Lescault A, Grenier A, Morrisette J, Gagné R, Gadbois P, Halket J

机构信息

Department of Genetic Medicine, Laval University Medical Centre, Ste-Foy, Quebec, Canada.

出版信息

Am J Hum Genet. 1990 Aug;47(2):329-37.

PMID:2378359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1683732/
Abstract

Homogentisic acid (HGA) (50 mg/kg) was given orally to 22 obligate heterozygotes for hereditary tyrosinemia type 1 (HT) and to 11 controls. After 1 h the mean +/- standard error (SE) plasma level of HGA was 30.42 +/- 1.41 micrograms/ml in carriers and 19.29 +/- 1.62 in controls. Mean +/- SE fasting delta-amino-levulinate dehydratase (delta-ALD) was 40.05 +/- 1.79 m microM/min/g Hb in carriers, much lower than the 60.81 +/- 5.11 found in controls. After 3 h this difference in levels of delta-ALD remained, with mean +/- SE values of 25.70 +/- 2.89 m microM/min/g Hb in carriers, compared with 48.83 +/- 5.37 in controls. Three-hour mean +/- SE excretion of fumarylacetone "equivalent" [FAc] in urine in carriers, 51.597 +/- 5.580 micrograms/mg/creatinine, was significantly higher than the 27.941 +/- 5.916 in controls. Three-hour excretion of succinylacetone "equivalent" [SAc] was also significantly higher in the urine of carriers. FAc in 3-h urine was identified by thin-layer chromatography and confirmed by gas chromatography/mass spectrometry. Multivariate stepwise discriminant analysis showed that the inclusion order of significant variables was as follows: HGA levels at 1 hr, fasting level of delta-ALD, residual level of HGA at 3 h, and 3-h excretion of [FAc]. Non-significant variables were HGA tolerance, levels of delta-ALD at 3 h, sex, and 3-h excretion of [SAc].(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

给22名遗传性1型酪氨酸血症(HT)的 obligate杂合子和11名对照口服尿黑酸(HGA)(50毫克/千克)。1小时后,携带者血浆HGA平均水平±标准误(SE)为30.42±1.41微克/毫升,对照为19.29±1.62微克/毫升。携带者平均±SE空腹δ-氨基-γ-酮戊酸脱水酶(δ-ALD)为40.05±1.79微摩尔/分钟/克血红蛋白,远低于对照的60.81±5.11。3小时后,δ-ALD水平的这种差异仍然存在,携带者平均±SE值为25.70±2.89微摩尔/分钟/克血红蛋白,对照为48.83±5.37。携带者尿中3小时平均±SE排泄的富马酰乙酰丙酮“当量”[FAc]为51.597±5.580微克/毫克/肌酐,显著高于对照的27.941±5.916。携带者尿中琥珀酰乙酰丙酮“当量”[SAc]的3小时排泄也显著更高。通过薄层色谱法鉴定3小时尿中的FAc,并通过气相色谱/质谱法确认。多变量逐步判别分析表明,显著变量的纳入顺序如下:1小时时的HGA水平、空腹δ-ALD水平、3小时时HGA的残留水平以及3小时时[FAc]的排泄。非显著变量为HGA耐受性、3小时时的δ-ALD水平、性别以及3小时时[SAc]的排泄。(摘要截短至250字)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2940/1683732/18102f3c0996/ajhg00092-0161-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2940/1683732/18102f3c0996/ajhg00092-0161-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2940/1683732/18102f3c0996/ajhg00092-0161-a.jpg

相似文献

1
Oral loading of homogentisic acid in controls and in obligate heterozygotes for hereditary tyrosinemia type I.对对照组和遗传性I型酪氨酸血症的纯合子进行尿黑酸口服负荷试验。
Am J Hum Genet. 1990 Aug;47(2):329-37.
2
Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.琥珀酰丙酮的检测及其在遗传性酪氨酸血症大规模筛查中的测量应用。
Clin Chim Acta. 1982 Aug 4;123(1-2):93-9. doi: 10.1016/0009-8981(82)90117-6.
3
On the enzymic defects in hereditary tyrosinemia.关于遗传性酪氨酸血症中的酶缺陷
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641-5. doi: 10.1073/pnas.74.10.4641.
4
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.遗传性酪氨酸血症与血红素生物合成途径。琥珀酰丙酮对δ-氨基乙酰丙酸脱水酶活性的深度抑制。
J Clin Invest. 1983 Mar;71(3):625-34. doi: 10.1172/jci110809.
5
Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Clin Chim Acta. 1985 Nov 15;152(3):271-9. doi: 10.1016/0009-8981(85)90102-0.
6
Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.琥珀酰丙酮可抑制δ-氨基乙酰丙酸脱水酶,并增强药物和类固醇对肝脏中δ-氨基乙酰丙酸合酶的诱导作用。
Trans Assoc Am Physicians. 1982;95:42-52.
7
Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.遗传性酪氨酸血症酶缺乏的生化研究。
Clin Chim Acta. 1983 Oct 31;134(1-2):129-41. doi: 10.1016/0009-8981(83)90191-2.
8
Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.遗传性酪氨酸血症。琥珀酰丙酮 - 氨基酸加合物的形成。
J Exp Med. 1985 Sep 1;162(3):1060-74. doi: 10.1084/jem.162.3.1060.
9
Quantitation of homogentisic acid in normal human plasma.
J Chromatogr B Biomed Appl. 1996 Feb 23;677(1):147-51. doi: 10.1016/0378-4347(95)00442-4.
10
Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Clin Chim Acta. 1981 Nov 11;116(3):331-41. doi: 10.1016/0009-8981(81)90052-8.

引用本文的文献

1
Phenotyping heterozygous carriers of juvenile neuronal ceroid lipofuscinosis with CLN3 mutations.对携带CLN3基因突变的青少年神经元蜡样脂褐质沉积症杂合子携带者进行表型分析。
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1245-50. doi: 10.1007/s00417-014-2814-0. Epub 2014 Oct 22.

本文引用的文献

1
Homogentisate metabolism: the isomerization of maleylacetoacetate by an enzyme which requires glutathione.尿黑酸代谢:由一种需要谷胱甘肽的酶催化马来酰乙酰乙酸的异构化反应。
J Biol Chem. 1956 May;220(1):79-91.
2
The properties of maleylacetoacetate, the initial product of homogentisate oxidation in liver.马来酰乙酰乙酸的性质,即肝脏中尿黑酸氧化的初始产物。
J Biol Chem. 1955 Oct;216(2):489-98.
3
Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Clin Chim Acta. 1981 Nov 11;116(3):331-41. doi: 10.1016/0009-8981(81)90052-8.
4
Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid.4,6-二氧代庚酸对δ-氨基乙酰丙酸脱水酶的抑制作用。
J Biol Chem. 1981 Oct 10;256(19):9915-23.
5
Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.遗传性酪氨酸血症的产前诊断:羊水琥珀酰丙酮的测定
Prenat Diagn. 1982 Jul;2(3):185-8. doi: 10.1002/pd.1970020307.
6
Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.琥珀酰丙酮的检测及其在遗传性酪氨酸血症大规模筛查中的测量应用。
Clin Chim Acta. 1982 Aug 4;123(1-2):93-9. doi: 10.1016/0009-8981(82)90117-6.
7
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.遗传性酪氨酸血症与血红素生物合成途径。琥珀酰丙酮对δ-氨基乙酰丙酸脱水酶活性的深度抑制。
J Clin Invest. 1983 Mar;71(3):625-34. doi: 10.1172/jci110809.
8
Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.遗传性酪氨酸血症患者淋巴细胞和成纤维细胞中富马酰乙酰乙酸富马酰水解酶活性缺乏。
Pediatr Res. 1983 Jul;17(7):541-4. doi: 10.1203/00006450-198307000-00005.
9
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.一名遗传性肝肾酪氨酸血症患者的生化研究:谷胱甘肽缺乏的证据。
Pediatr Res. 1984 Dec;18(12):1332-6. doi: 10.1203/00006450-198412000-00023.
10
Hereditary tyrosinemia in a French Canadian isolate.法裔加拿大人群体中的遗传性酪氨酸血症。
Am J Hum Genet. 1969 Jan;21(1):36-45.